Training a phage to expand its host range: directed evolution against Staphylococcus aureus from diabetic foot infections
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.00639-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Lucile Plumet und 8 weiteren Autor:innen. Beteiligte Einrichtung: VBIC, INSERM U1047, Department of Microbiology and Hospital Hygiene, University of Montpellier, CHU Nîmes, Nîmes, France. Hauptthemen laut MEDLINE: Diabetic Foot, Staphylococcus aureus, Staphylococcal Infections, Phage Therapy. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Diabetic foot infections (DFIs) are a major complication of diabetes frequently involving multidrug-resistant Staphylococcus aureus . Their persistence and therapeutic complexity underscore the urgent need for alternatives to conventional antibiotics. Phage therapy offers a promising solution, though its clinical application is often limited by the narrow host range of individual phages. Here, SAVM02, a recently characterized staphylococcal Kayvirus , was trained using directed evolution against DFI isolates. After 20 iterative passages on a mixed panel of susceptible and non-susceptible S. aureus strains, the trained phage pool (SAVM02-P20) displayed markedly enhanced activity, infecting approximately 77% of tested S. aureus isolates and showing partial cross-species activity against coagulase-negative staphylococci. Improved infectivity was linked to increased replication efficiency rather than adsorption. Genomic and phylogenetic analyses further suggested recurrent adaptive changes and preferential host-range expansion within genetically related lineages. In vivo testing in a zebrafish embryo model confirmed therapeutic efficacy against a fully susceptible strain but revealed no survival benefit against an initially poorly permissive isolate, highlighting the gap between in vitro adaptation and in vivo efficacy. These findings demonstrate both the potential and the limitations of phage training to expand therapeutic coverage and emphasize the need to integrate evolutionary approaches with physiologically relevant models to optimize phage therapy for chronic infections, such as DFIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VBIC, INSERM U1047, Department of Microbiology and Hospital Hygiene, University of Montpellier, CHU Nîmes, Nîmes, France.
- Genomic Research Laboratory, University Hospitals of Geneva, Service of Infectious Diseases and Faculty of Medicine, Geneva, Switzerland.
- Greenphage, Cap Alpha, Clapiers, France.
ORCID-Profile: Lucile Plumet, Jean-Philippe Lavigne, Denis Costechareyre, Virginie Molle
Zitieren
APA
Plumet, L., Magnan, C., Morsli, M., Richardoz, M., Gaïa, N., François, P., Lavigne, J. P., Costechareyre, D., & Molle, V. (2026). Training a phage to expand its host range: directed evolution against Staphylococcus aureus from diabetic foot infections. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00639-26
Vancouver
Plumet L, Magnan C, Morsli M, Richardoz M, Gaïa N, François P, et al. Training a phage to expand its host range: directed evolution against Staphylococcus aureus from diabetic foot infections. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00639-26
BibTeX
@article{Plumet2026,
author = {Plumet, Lucile and Magnan, Chloé and Morsli, Madjid and Richardoz, Marion and Gaïa, Nadia and François, Patrice and Lavigne, Jean-Philippe and Costechareyre, Denis and Molle, Virginie},
title = {Training a phage to expand its host range: directed evolution against Staphylococcus aureus from diabetic foot infections},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00639-26}
}
EUVIMED